Focus Area highlights

We have worked with our Focus Area Leads to ensure that there is a wealth of content for every area of endocrinology. We caught up with representatives for each of ESE's eight key Focus Areas to find out about their personal programme highlights.

Adrenal and Neuroendocrine Tumours 

Symposium 2: New Horizons in Phaeochromocytoma and Paraganglioma

"I am excited to hear this session's talk on the Prognosis for Malignant Phaeochromocytoma. This talk is quite important since at the moment there are no markers which accurately predict outcome of these tumours. This session also focuses on Combination Targeted Therapies for Malignant Tumours, another very important topic as malignant pheochromocytoma is a rare disease, without curative treatment available yet."

Symposium 29: Innovations in NETS

"I am very interested in the talk on new TKI's for pancreatic NETS given in session. The incidence of these tumors is increasing. They have complex clinical and biochemical behaviour and current treatment strategies for advanced disease are not ideal. Learning about innovations in this area is key."

Darko Kastelan, Clinical Lead for the Adrenal and Neuroendocrine Tumours Focus Area

Calcium and Bone

Symposium 28: Parathyroid disorders: outcomes of the PARAT programme

"My personal programme highlights include. There is one talk focusing on the Challenges in the management of chronic hypoparathyroidism I am particularly interested in. This is a hot topic right now with several new treatments in development."

Lars Rejnmark, Clinical Lead for the Calcium and Bone Focus Area

Clinical Endocrinology Trust Lecture: Postmenopausal osteoporosis: balancing the risks and benefits

"We are looking forward to the Clinical Endocrinology Trust Lecture given by Richard Eastell. Postmenopausal osteoporosis is a very common disease and is of great interest to clinicians and researchers alike."

Wim van Hul, Basic Lead for the Calcium and Bone Focus Area

Diabetes, Obesity and Metabolism

Plenary 5: Harnessing the microbiome in metabolic disease

"The role of the microbiome in metabolic disease is one of the hottest topics in the field of endocrinology today. This is why my personal highlights include this session examining how we can use the microbiome to improve patient outcomes. 

Daniela Cota, Basic Lead for the Diabetes, Obesity and Metabolism Focus Area

Symposium 16: Controversial issues in bariatric surgery

"This has caught my attention as Bariatric surgery is performed increasingly more frequently, despite the fact that correct selection of patients, choice of optimal surgical procedure, postoperative care and outcome remain to be established or optimised."

Anton Luger, Clinical Lead for Diabetes, Obesity and Metabolism Focus Area

Environment Society and Governance 

Symposium 5: Large ambitious and inspiring European prevention programs

 "This session will address some impressive and very successful Europe- and worldwide projects. For example the Cities changing diabetes project that enables cities over the world to involve their inhabitants in prevention and treatment projects to fight the global obesity pandemic. The session will also take a look at the Prevention program for male health as example of how large and ambitious projects can be successful. Finally, in the same symposium, we will bring into the spotlight the EU-thyroid project, which brings together data from 16 countries."

Symposium 10: The future of medicine, Artificial Intelligence (AI) and big data!

"In this symposium we will discuss the radical changes that everybody in the field of medicine will be exposed to. Experts in the field will present their revolutionary vision on the future of AI in radiology and imaging. But also, the developments in AI and machine learning in endocrinology and metabolism and big data in endocrine diseases will be discussed, so we’re very sure that this symposium will draw a lot of attention."

AJ van der Lely Representative for the Environment Society and Governance Focus Area

Pituitary and Neuroendocrinology

Symposia 23: Difficult pituitary tumour cases

"I am excited to see this session's talk on functional imaging in difficult pituitary cases. This is an emerging field and its diagnostic usefulness needs clarification."

Jens Otto Jørgensen, Clinical Lead for the Pituitary and Neuroendocrinology Focus Area

Reproductive Endocrinology

Symposium 9: Emerging concerns in male reproduction

"One talk in particular has caught my attention; Hypothalamic neuropeptides modulate sex, senses and emotion in humans as it will cover kisspeptins. Kisspeptins have emerged as key players in reproduction. The work from speaker Waljit Dhillo and colleagues has exposed the dimension of kisspeptins as modulators of sex behaviours and emotions in humans which is quite novel and interesting."

Manuel Tena-Sempere, Basic Lead for the Reproductive Endocrinology Focus Area


Meet The Expert 3: 30 years of molecular genetic testing of thyroid cancer

For me this is a talk of great clinical interest. It's also great to get the view of the speaker Bela Bendlova as a specialist working in our host country, the Czech Republic."

Clara Alverez, Representative of the Thyroid Focus Area 

Meet The Expert Basic Scientist 3: Environmental disruptions of the thyroid hormone axis?

"Endocrine disruptors are constantly coming up as important in both basic and clinical science. It is a puzzle which needs to be resolved, this session should provide part of the picture."

Leonidas Duntas, Representative of the Thyroid Focus Area 

These are just some of the fascinating and boundary pushing sessions at available ECE 2020. Take a look at our the Scientifc Programme to learn more. 

Subscribe to our email alerts